These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance. Ballard KD; Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD Atherosclerosis; 2013 Sep; 230(1):121-4. PubMed ID: 23958263 [TBL] [Abstract][Full Text] [Related]
4. Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system. Sahebkar A; Cicero AFG; Di Giosia P; Pomilio I; Stamerra CA; Giorgini P; Ferri C; von Haehling S; Banach M; Jamialahmadi T J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1177-1186. PubMed ID: 32743965 [TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design. Thompson PD; Parker BA; Clarkson PM; Pescatello LS; White CM; Grimaldi AS; Levine BD; Haller RG; Hoffman EP Prev Cardiol; 2010; 13(3):104-11. PubMed ID: 20626664 [TBL] [Abstract][Full Text] [Related]
6. The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. Kearns AK; Bilbie CL; Clarkson PM; White CM; Sewright KA; O'Fallon KS; Gadarla M; Thompson PD Atherosclerosis; 2008 Sep; 200(1):121-5. PubMed ID: 18261731 [TBL] [Abstract][Full Text] [Related]
7. No adverse effects of statins on muscle function and health-related parameters in the elderly: an exercise study. Panayiotou G; Paschalis V; Nikolaidis MG; Theodorou AA; Deli CK; Fotopoulou N; Fatouros IG; Koutedakis Y; Sampanis M; Jamurtas AZ Scand J Med Sci Sports; 2013 Oct; 23(5):556-67. PubMed ID: 22288788 [TBL] [Abstract][Full Text] [Related]
8. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. Laaksonen R; Katajamaa M; Päivä H; Sysi-Aho M; Saarinen L; Junni P; Lütjohann D; Smet J; Van Coster R; Seppänen-Laakso T; Lehtimäki T; Soini J; Oresic M PLoS One; 2006 Dec; 1(1):e97. PubMed ID: 17183729 [TBL] [Abstract][Full Text] [Related]
9. Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise. Chung J; Brass EP; Ulrich RG; Hiatt WR Clin Pharmacol Ther; 2008 Feb; 83(2):243-50. PubMed ID: 17554242 [TBL] [Abstract][Full Text] [Related]
11. Comment and reply on: Atorvastatin: safety and tolerability. Statins and polymyositis: a neglected link? Famularo G; Minisola G; Gasbarrone L Expert Opin Drug Saf; 2010 Nov; 9(6):1005-6; author reply 1006. PubMed ID: 20919802 [No Abstract] [Full Text] [Related]
12. [Statin therapy and muscle disorders]. Abel T; Fehér J Orv Hetil; 2009 Feb; 150(6):261-3. PubMed ID: 19179258 [No Abstract] [Full Text] [Related]
13. Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy. Skottheim IB; Bogsrud MP; Hermann M; Retterstøl K; Åsberg A Mol Diagn Ther; 2011 Aug; 15(4):221-7. PubMed ID: 21815705 [TBL] [Abstract][Full Text] [Related]
14. Myopathy after switching from brand to generic atorvastatin. Awoniyi O; Gosmanov AR J Am Geriatr Soc; 2013 Dec; 61(12):2254-2255. PubMed ID: 24329838 [No Abstract] [Full Text] [Related]
15. Systemic infections can decrease the threshold of statin-induced muscle injury. Mahboobi SK; Shohat EZ; Jellinek SP; Rose M South Med J; 2006 Apr; 99(4):403-4. PubMed ID: 16634254 [No Abstract] [Full Text] [Related]
16. Summaries for patients. Muscle abnormalities in four patients taking statins to treat unfavorable cholesterol levels. Ann Intern Med; 2002 Oct; 137(7):I45. PubMed ID: 12353973 [No Abstract] [Full Text] [Related]
17. Mitochondria of trained skeletal muscle are protected from deleterious effects of statins. Bouitbir J; Daussin F; Charles AL; Rasseneur L; Dufour S; Richard R; Piquard F; Geny B; Zoll J Muscle Nerve; 2012 Sep; 46(3):367-73. PubMed ID: 22907227 [TBL] [Abstract][Full Text] [Related]
18. The effect of statins on skeletal muscle function: the STOMP trial. Farmer JA Curr Atheroscler Rep; 2013 Aug; 15(8):347. PubMed ID: 23843151 [No Abstract] [Full Text] [Related]
19. Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients. Newman C; Tsai J; Szarek M; Luo D; Gibson E Am J Cardiol; 2006 Jan; 97(1):61-7. PubMed ID: 16377285 [TBL] [Abstract][Full Text] [Related]
20. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin. Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]